Toxikon showcasing preclinical testing services at DeviceTalks Boston

Share

ToxikonToxikon is a preclinical Contract Research Organization (CRO) located in an FDA registered and ISO 17025 accredited laboratory facility in Bedford, Mass., and a second European lab operation in Leuven, Belgium. The company contracts and partners with biotech, pharmaceutical and medical device industries to deliver product development services from concept to final product. Its professional and scientific staff is experienced in a comprehensive range of compound structures, therapeutic agents, and medical devices, including combinations products.

Featured services:

  • ISO 10993 biocompatibility safety studies (GLP)
  • Preclinical early efficacy and surgical research
  • Chemical characterization/extractables and leachables
  • Cleaning, disinfection and sterilization validations

Visit Toxikon at booth #202 at DeviceTalks Boston.

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

Last Chance to Save for DeviceTalks Boston!

textadimage Early rates for DeviceTalks Boston end August 15th.

Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.

View Full Agenda

Register today to save. Use code LASTCALL to save an additional 10%.

Speak Your Mind

*